Trial intelligence / Profile preview

Coarsucam vs Coartem in Uncomplicated P. falciparum Malaria

NCT00316329Phase 3Completed

Sponsor
Sanofi
Start
Mar 2006
Modality
Small Molecules
Countries
4
01

Overview

A Phase 3 trial of artesunate + amodiaquine in Plasmodium falciparum malaria, sponsored by Sanofi. Started Mar 2006; status: completed.

02

Drugs

artesunate + amodiaquine
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT00316329.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00316329.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call